NRIX · Two C-suite insiders at Nurix Therapeutics (CSO and CLO) sold a…

Two C-suite insiders at Nurix Therapeutics (CSO and CLO) sold a combined $208K in open-market sales, with the CSO's sale executed under a 10b5-1 plan. The total is 0.007% of the $3.0B market cap, well below the 0.1% materiality threshold, making this a routine, non-informative cluster.

• Chief Scientific Officer Gwenn Hansen sold 4.0K shares at $26.28 for $104K under a 10b5-1 plan
• Chief Legal Officer Christine Ring sold 4.0K shares at $26.28 for $104K without a 10b5-1 plan
• Total open-market sales of $208K represent 0.007% of the $3.0B market cap
• Both sales followed derivative exercises (non-cash, $0 value) that generated the shares sold